Glossary category
Analytical chemistry
Terms describing the determination of identity, purity, content and quality.
Terms
35 documents
Table 1. Terms in the analytical chemistry category.
| Term | Definition |
|---|---|
| Adsorption | Loss of peptide to container and syringe surfaces, material at low concentration in the absence of a surfactant. A source of content loss that no certificate reports. |
| AggregationFibrillation | Association of peptide molecules into higher-order species, driven by agitation, freeze–thaw cycling and proximity to the isoelectric point. Not detected by a reverse-phase purity method and requires size-exclusion analysis. |
| Average mass | The mass calculated using isotope-averaged atomic weights, and the value returned by deconvolution of an electrospray charge envelope at moderate resolution. |
| Chromatographic purityArea percentage purity · HPLC purity | The area of the main peak as a percentage of total integrated area under stated conditions. A relative measure that assumes comparable molar absorptivity across species and that does not detect anything without a chromophore. |
| Counter-ionSalt form | The ion paired with a charged peptide, most often trifluoroacetate or acetate from purification. Can constitute a substantial fraction of the mass of a basic peptide and is not detected by a purity method. |
| Deamidation | Conversion of asparagine or glutamine to the corresponding acid, adding one dalton and altering charge. A principal storage-related degradation route for peptides in solution. |
| Deletion sequence | An impurity lacking one or more residues, arising from incomplete coupling during synthesis. Often close-eluting and detectable only by mass spectrometry. |
| Enantiomeric purityChiral purity | The proportion of residues in the intended stereochemical configuration. Racemisation during synthesis produces species of identical mass and identical reverse-phase retention, detectable only by a chiral method. |
| EndotoxinBacterial endotoxin · LPS | Lipopolysaccharide from Gram-negative bacterial cell walls, pyrogenic on parenteral administration. Determined by a lysate-based or recombinant assay against a dose- and route-dependent limit, and reported essentially never in the research-supply channel. |
| Forced degradationStress testing | Deliberate exposure of a sample to heat, light, acid, base and oxidant to generate degradation products against which a method’s specificity is demonstrated. |
| Freeze–thaw | Repeated freezing and thawing of a solution. Concentrates solutes in the shrinking liquid fraction, drives pH excursion as buffer components crystallise differentially, and promotes aggregation. |
| Gradient | The programmed change in mobile-phase composition over a chromatographic run. A shallow gradient resolves close-eluting species that a steep gradient co-elutes, and the two report different purities for the same material. |
| Identity | Confirmation that the material is the substance claimed. Retention-time correspondence alone is weak evidence of identity; mass-spectrometric confirmation of the expected mass is stronger; sequence confirmation is stronger still. |
| In-use periodBeyond-use date | The time a reconstituted preparation may be stored and used, supported by stability-indicating data on that presentation. The Institute publishes no in-use claim for any research-supply presentation because no such data exist for one. |
| Integration window | The retention-time range over which peak areas are summed. Changing the window changes the reported purity without changing the material, which is why the Institute requires the window to be reported. |
| Isomerisation | Conversion of aspartate to isoaspartate through a succinimide intermediate, producing a species of identical mass and different retention. Undetectable by mass alone. |
| Karl Fischer titrationKF | The reference method for water content, based on the stoichiometric reaction of water with iodine and sulfur dioxide. The only water determination the Institute accepts for a hygroscopic lyophilisate. |
| Limit of detectionLOD | The lowest concentration at which the presence of a species can be distinguished from noise. Lower than the limit of quantitation and not a basis for a numerical result. |
| Limit of quantitationLOQ | The lowest concentration at which a determination can be made with stated precision and accuracy. An impurity below the limit is not absent; it is unquantified. |
| Mass balance | The sum of peptide content, water content and counter-ion content, which should approach one hundred per cent. A certificate that does not permit a mass balance to be closed is incomplete under the Institute’s minimum data standard. |
| Mass spectrometryMS · ESI-MS | Determination of mass-to-charge ratio, used to confirm identity. For a peptide, deconvolution of the multiply charged envelope should return an average mass within a stated tolerance of the theoretical value. |
| Monoisotopic mass | The mass calculated using the most abundant isotope of each element. Requires high resolving power to determine for a peptide of several kilodaltons, and is not interchangeable with average mass. |
| Orthogonal method | A second analytical method resting on a different physical principle from the first. Identity confirmed by two orthogonal methods is materially stronger than identity confirmed by one, and is required by the Institute’s minimum data standard. |
| Oxidation | Addition of oxygen to methionine, tryptophan or cysteine, adding sixteen daltons. Accelerated by peroxide, light and metal ions. |
| Peptide contentPeptide assay | The mass fraction of a lyophilisate that is peptide, the remainder being water, counter-ion and residual solvent. Determined by amino-acid analysis or nitrogen determination. Distinct from purity, and the two are frequently conflated. |
| Peptide mapping | Enzymatic digestion followed by chromatographic and mass-spectrometric analysis of the resulting fragments, used to confirm sequence. Rarely performed on research-supply material. |
| Reference standard | A characterised material with an assigned content value against which a determination is made. A result obtained without a named standard reports an area percentage rather than a content. |
| Related substancesImpurities | Impurities structurally related to the target peptide, arising from synthesis or degradation. Reported by name and retention time on a complete certificate and as a single aggregate figure on most. |
| Reverse-phase HPLCRP-HPLC | Separation on a hydrophobic stationary phase under an acidified aqueous–organic gradient, with ultraviolet detection at 214 nanometres. The Institute’s reference method for the chromatographic purity of synthetic peptides. |
| Size-exclusion chromatographySEC | Separation by hydrodynamic radius, the standard method for aggregate determination. Reported on no certificate in the Institute’s sampled set. |
| Stability-indicating | A property of a method that separates the intact compound from its degradation products, demonstrated by forced-degradation study. A purity method that is not stability-indicating cannot support a shelf-life or in-use claim. |
| Sterility | The absence of viable microorganisms, demonstrated by a compendial test on the finished presentation. Distinct from endotoxin content, which persists after sterilisation. |
| System suitability | A set of criteria confirmed at the time of analysis establishing that the chromatographic system is performing adequately. A result obtained on a system failing suitability is not reportable. |
| TrifluoroacetateTFA | The counter-ion most commonly introduced by reverse-phase purification with trifluoroacetic acid. Quantified by ion chromatography or fluorine nuclear magnetic resonance, and reported on few certificates. |
| Water contentResidual moisture | The mass fraction of a lyophilisate that is water. Substantial for a hygroscopic peptide and a direct subtraction from delivered peptide mass. |